Gavi, the Vaccine Alliance, will help vaccinate up to 45 million children in seven developing countries over the next six months in a series of major vaccination campaigns to help halt a recent surge in global measles cases.<\/p>\n
The seven developing countries targeted by the vaccination campaigns are Bangladesh, Central Africa, Ethiopia, Kenya, Nepal, Somalia, and South Sudan.<\/p>\n
The campaigns will be carried out by governments with funding from Gavi and support from Vaccine Alliance and Measles & Rubella Initiative (M&RI) partners, including World Health Organization (WHO) and UNICEF.<\/p>\n
They will target children under five years old, the age group most vulnerable to the disease, with Bangladesh also aiming to reach children under nine years old.<\/p>\n
In addition Gavi, with support from Vaccine Alliance partners, will help Madagascar and Mauritania introduce a second dose of measles-containing vaccine into their routine immunization programs.<\/p>\n
Over a million children every year in the two countries will receive this vital second dose, which increases the vaccine\u2019s effectiveness from around 84 per cent\u00a0to per cent.<\/p>\n
Reported measles cases worldwide fell from over 850,000 in 2000 to 132,000 in 2016, largely as a result of increases in vaccine coverage in the world\u2019s poorest countries. However, in recent years cases have surged dramatically. In 2018 there were nearly 360,000 cases recorded globally. Provisional data reported to WHO shows this climbed again in 2019, with almost 430,000 cases reported for the year to date.<\/p>\n
\u201cThe measles vaccine is safe, effective and low-cost \u2013 there is no reason children should still be dying of this disease,\u201d said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance.<\/p>\n
\u201cWhile the headlines might focus on rising cases in Europe and the US, it is sadly still the case that the vast majority of measles deaths are happening in the world\u2019s poorest countries, where poor health systems mean children are often left to fight the disease without treatment or support. That\u2019s why these vaccination campaigns are so important, protecting the next generation so they can survive and thrive in later life. The use of tailored and targeted approaches in these campaigns is vital to ensure we leave no child behind.\u201d<\/p>\n
\u201cMeasles is a devastating disease that is causing severe sickness and taking lives,\u201d said Dr Tedros Adhanom Ghebreyesus, Director-General of WHO. \u201cNo matter where they live, vaccination helps children survive, thrive, and lead a long and healthy life. WHO is proud to be working with Gavi and partners to ensure lifesaving measles vaccines reach where they are needed most.\u201d<\/p>\n
\u201cMeasles cases rose alarmingly in 2019, affecting hundreds of thousands of children and claiming many young lives,\u201d said Henrietta Fore, UNICEF Executive Director. \u201cWe need to vaccinate every child.\u00a0These measles outbreaks have taught us that we need to stay vigilant. We can\u2019t afford to wait and watch.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
Gavi, the Vaccine Alliance, will help vaccinate up to 45 million children in seven developing countries over the next six months in a series of major vaccination campaigns to help halt a recent surge in global measles cases. The seven developing countries targeted by the vaccination campaigns are Bangladesh, Central Africa, Ethiopia, Kenya, Nepal, Somalia, […]<\/p>\n","protected":false},"author":410,"featured_media":51934,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6031,984],"tags":[8317,8316],"yoast_head":"\n